Head-To-Head Survey: TransEnterix (TRXDW) & Its Competitors

Insider & Institutional Ownership

8.2% of TransEnterix shares are owned by institutional investors. Comparatively, 22.5% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are owned by institutional investors. 3.1% of TransEnterix shares are owned by insiders. Comparatively, 18.1% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares TransEnterix and its peers top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
TransEnterix	$8.53 million	-$154.20 million	-0.04
TransEnterix Competitors	$58.84 million	-$32.15 million	4.18

TransEnterix’s peers have higher revenue and earnings than TransEnterix. TransEnterix is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Volatility and Risk

TransEnterix has a beta of 2.56, indicating that its share price is 156% more volatile than the S&P 500. Comparatively, TransEnterix’s peers have a beta of 1.76, indicating that their average share price is 76% more volatile than the S&P 500.

Profitability

This table compares TransEnterix and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TransEnterix	-2,149.15%	-83.74%	-64.94%
TransEnterix Competitors	-672.41%	-133.75%	-59.01%

Summary

TransEnterix peers beat TransEnterix on 7 of the 9 factors compared.

About TransEnterix

TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.